The life sciences industry is evolving rapidly, raising expectations for agencies, brands, and commercialization partners alike. Success is no longer measured by the volume of work produced, but by the outcomes those efforts deliver.
In this interview with Fierce Pharma, EVERSANA INTOUCH CEO Mike Guarino shares his perspective on how EVERSANA INTOUCH is evolving to meet these changing demands. As the industry shifts from outputs to outcomes, marketers must consider the entire commercialization continuum.
Mike also explores how AI and data are transforming the industry, not by replacing creativity, but by strengthening it. As pharmaceutical companies gain access to richer insights and more advanced technologies, the opportunity lies in turning those insights into meaningful stories that resonate with healthcare professionals, patients, and caregivers.
“Nobody remembers the data. They remember the story the data told.”
As the healthcare landscape becomes increasingly data-driven, success will belong to organizations that can turn insights into action, data into stories, and innovation into measurable outcomes.
Watch the interview below to hear Mike’s perspective on the future of healthcare commercialization and why being a true “category of one” requires more than technology alone.